David Shay / Wikimedia Commons / CC BY-SA 4.0 / December 2015 archive
Teva Pharmaceuticals says it remains committed to supplying high-quality medicines and working with healthcare professionals in Ireland after the Irish Hospital Consultants Association approved a motion encouraging members to avoid its products when clinically appropriate alternatives are available.
The company said in a statement Sunday that it was “disappointed” by the decision and respectfully disagreed with it. Teva placed patient care and the continuity of its work with Irish healthcare professionals at the center of its response.
“Healthcare shouldn’t be politicized, and treatment decisions should be guided by clinical evidence, patient need, and professional judgment,” Teva said.
“Any action that seeks to restrict access to medicines for reasons unrelated to patient care risks undermining the principle that patients should receive the treatment most appropriate for their condition,” it said.
The consultants’ motion is conditional: it encourages avoiding Teva medicines where clinically appropriate and equivalent alternatives exist, provided that doing so does not compromise patient safety, continuity of treatment or clinical outcomes. It is a professional association’s position, not a government ban on the company’s medicines.
Teva said it is proud to have produced medicines in Ireland for more than 30 years, serving patients and healthcare professionals in the country and around the world. Despite its disagreement with the motion, the company said it remains committed to working constructively with Irish professionals and supporting patients through the “consistent supply of high-quality medicines.”
JBizNews Desk | New York
© JBizNews.com. All rights reserved. Unauthorized reproduction or redistribution is strictly prohibited.
